Fresenius Medical Care Reports Strong Q1 2026 Earnings with Revenue Growth and Margin Expansion
Fresenius Medical Care AG (FMS) reported organic revenue growth of 4% in the first quarter of 2026, driven by performance across all segments. The company achieved a 70 basis point increase in operating income margin to 10.1%, and completed its EUR 1 billion share buyback program ahead of schedule.
Tickers: $FMS
Topics: margin_expansion operating_income revenue_growth share_buyback